Paper41781978
Narratives and tensions in the ethics of human proteomics literature: a scoping review.
Devos I and 1 other. BMC Med Ethics, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Narratives and tensions in the ethics of human proteomics literature: a scoping review. Papers, record 41781978. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41781978
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| FN 701000004 | Fonds Wetenschappelijk Onderzoek | PubMed |
Source PubMed
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21473728 | Analysis of protein biomarkers in human clinical tumor samples: critical aspects to success from tissue acquisition to analysis. | Biomark Med | 2011 | https://conductscience.org/library/papers/21473728 | PubMed |
| 2 | 12544482 | Genetic advances will influence the practice of medicine: examples from cancer research and care of cancer patients. | Genet Med | 2002 | https://conductscience.org/library/papers/12544482 | PubMed |
| 3 | 20455752 | Standardization and omics science: technical and social dimensions are inseparable and demand symmetrical study. | OMICS | 2010 | https://conductscience.org/library/papers/20455752 | PubMed |
| 4 | 11317426 | Defining and describing benefit appropriately in clinical trials. | J Law Med Ethics | 2000 | https://conductscience.org/library/papers/11317426 | PubMed |
| 5 | 36523653 | Identifying individuals using proteomics: are we there yet? | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/36523653 | PubMed |
| 6 | 25857810 | Multidimensional proteomics for cell biology. | Nat Rev Mol Cell Biol | 2015 | https://conductscience.org/library/papers/25857810 | PubMed |
| 7 | 29077858 | Proteomics and phosphoproteomics in precision medicine: applications and challenges. | Brief Bioinform | 2019 | https://conductscience.org/library/papers/29077858 | PubMed |
| 8 | 33444735 | Plasma Proteomes Can Be Reidentifiable and Potentially Contain Personally Sensitive and Incidental Findings. | Mol Cell Proteomics | 2021 | https://conductscience.org/library/papers/33444735 | PubMed |
| 9 | 35802789 | Big Health Data Research and Group Harm: The Scope of IRB Review. | Ethics Hum Res | 2022 | https://conductscience.org/library/papers/35802789 | PubMed |
| 10 | 34723319 | The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. | Nucleic Acids Res | 2022 | https://conductscience.org/library/papers/34723319 | PubMed |
| 11 | 29476807 | Advancing translational research and precision medicine with targeted proteomics. | J Proteomics | 2018 | https://conductscience.org/library/papers/29476807 | PubMed |
| 12 | 38404932 | Proteomics and Its Current Application in Biomedical Area: Concise Review. | ScientificWorldJournal | 2024 | https://conductscience.org/library/papers/38404932 | PubMed |
| 13 | 24228635 | Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration. | BMC Med | 2013 | https://conductscience.org/library/papers/24228635 | PubMed |
| 14 | 36744821 | Toward an Integrated Machine Learning Model of a Proteomics Experiment. | J Proteome Res | 2023 | https://conductscience.org/library/papers/36744821 | PubMed |
| 15 | 24886498 | Cohort profile: Greifswald approach to individualized medicine (GANI_MED). | J Transl Med | 2014 | https://conductscience.org/library/papers/24886498 | PubMed |
| 16 | 26645377 | Personalized medicine beyond genomics: alternative futures in big data-proteomics, environtome and the social proteome. | J Neural Transm (Vienna) | 2017 | https://conductscience.org/library/papers/26645377 | PubMed |
| 17 | 24412545 | Challenges and prospects for biomarker research: a current perspective from the developing world. | Biochim Biophys Acta | 2014 | https://conductscience.org/library/papers/24412545 | PubMed |
| 18 | 15634359 | Sicily statement on evidence-based practice. | BMC Med Educ | 2005 | https://conductscience.org/library/papers/15634359 | PubMed |
| 19 | 31492022 | Beyond Genes: Re-Identifiability of Proteomic Data and Its Implications for Personalized Medicine. | Genes (Basel) | 2019 | https://conductscience.org/library/papers/31492022 | PubMed |
| 20 | 30308031 | Considerations for ethics review of big data health research: A scoping review. | PLoS One | 2018 | https://conductscience.org/library/papers/30308031 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41781978
GET https://conductscience.org/api/papers/v1/41781978/references?page=2